Source comparison
MOTS-c Myths Cost Money Health: Comparison
Oral MOTS-c supplements boost metabolism No human trials on oral forms; animal data shows minimal absorption Gastric enzymes cleave peptide bonds. Less than 2% reaches circulation intact $80–$150/month for unabsorbed amino acids Oral forms are a bioavailabilit
This comparison does not assign a generated winner or score.
- Oral MOTS-c supplements boost metabolism
- No human trials on oral forms; animal data shows minimal absorption
- Gastric enzymes cleave peptide bonds. Less than 2% reaches circulation intact
- $80–$150/month for unabsorbed amino acids
- Oral forms are a bioavailability failure. Not worth the cost
- Injectable MOTS-c reverses insulin resistance
- Preliminary human data shows improved glucose markers in small trials; no Phase 3 validation
- Subcutaneous injection bypasses GI tract if stored correctly and reconstituted with bacteriostatic water
- $200–$400/month vs $25–$50/month for metformin (proven insulin sensitiser)
- Shows promise but lacks clinical validation to justify cost over proven drugs
- MOTS-c prevents age-related muscle loss
- Mouse studies show preservation of lean mass; human sarcopenia trials have not been conducted
- Requires cold chain integrity from synthesis to injection. Most consumer channels fail this
- $250–$500/month vs $0–$100/month for resistance training programs with established efficacy
- Animal data doesn't translate to human dosing recommendations yet
- MOTS-c is 'natural' and safer than pharmaceuticals
- It is endogenous (produced by mitochondria), but exogenous dosing safety profile is unknown beyond pilot studies
- Endogenous production is nanogram-scale; injectable doses are microgram-scale. Different magnitude entirely
- Variable; unregulated sources carry contamination risk
- 'Natural' doesn't mean safe at therapeutic doses. Safety data is incomplete